Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
Conditions
- Alzheimer's Disease (AD)
- Parkinson's Disease (PD)
- Chronic Traumatic Encephalopathy (CTE)
- Progressive Supranuclear Palsy (PSP)
- Frontal Temporal Dementia (FTD)
- Pick's Disease
- Tauopathies
Interventions
- DRUG: [18F]T807 ([18F]MNI-777)
Sponsor
Molecular NeuroImaging
Collaborators